Proteasome inhibitors: new class of antitumor agents
The ubiquitin-proteasome pathway is the principal pathway for intracellular protein degradation1,2 (Fig 1). This pathway selectively degrades an extensive number of short-lived regulatory proteins involved in the control of normal cellular processes. In order to be degraded, proteins targeted by the...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2003-11-01
|
| Series: | Bosnian Journal of Basic Medical Sciences |
| Online Access: | http://www.bjbms.org/ojs/index.php/bjbms/article/view/3484 |